Importantly, depletion of HK2/ROCK2 restored the blood vessel supporting function of TPC, while treatment of HK2 inhibitor induces MLC2-driven tumor vasculature remodeling to enhance chemotherapy delivery and efficacy against tumor growth. This evidence concerns the gene MYL2 and neoplasm.